Virtual Screening Reveals Aprepitant to Be a Potent Inhibitor of Neutral Sphingomyelinase 2: Implications in Blockade of Exosome Release in Cancer Therapy.
Journal of cancer research and clinical oncology（2023）
关键词
Aprepitant,Drug repositioning,Neutral sphingomyelinase 2,Exosomes,Drug resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要